Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02717130 · ClinicalTrials.gov registry record · NA
Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
A NA study, sponsored by Florida Atlantic University.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02717130: Clinical Trial NA study, sponsored by Florida Atlantic University.
NCT02717130 is a NA study that was terminated before completion, run by Florida Atlantic University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02717130, a NA study, was terminated before completion, sponsored by Florida Atlantic University.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
An Open-label, Multi-center, Longitudinal, Within-subject Comparison Study to Evaluate the Effects of Aripiprazole Once Monthly in Subjects with Schizophrenia on 30-, 90-, and 180- day Re-hospitalization Rates Following Hospital Discharge Compared with Retrospective Re-hospitalization Rates while on Oral Antipsychotic Medication.
Primary Outcome
Psychiatric re-hospitalization were planning to be assessed using hospital admission records. Study stopped due to lack of enrollment.
Interventions
- DRUG Aripiprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2016-06-08 |
| Est. Completion | 2017-05-25 |
| Phase | NA |
Why NCT02717130 stopped before completion
NCT02717130 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Aripiprazole is the first listed.
NCT02717130 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02717130 about?
NCT02717130 is a clinical study titled "Aripiprazole, Abilify Maintena Collaborative Clinical Protocol". An Open-label, Multi-center, Longitudinal, Within-subject Comparison Study to Evaluate the Effects of Aripiprazole Once Monthly in Subjects with Schizophrenia on 30-, 90-, and 180- day Re-hospitalization Rates Following Hospital Discharge Compared with Retrospective Re-hospitalization Rates while on...
What is the current status of trial NCT02717130?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2016-06-08. Estimated completion is 2017-05-25.
What interventions are being tested in trial NCT02717130?
The interventions under investigation include: Aripiprazole (DRUG).
Who is sponsoring clinical trial NCT02717130?
This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02717130's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI